NDC 55292-702

Panhematin

Hemin

Panhematin is a Intravenous Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases, Inc.. The primary component is Hemin.

Product ID55292-702_997ac971-218e-4936-a26c-807f3c4d8f3a
NDC55292-702
Product TypeHuman Prescription Drug
Proprietary NamePanhematin
Generic NameHemin
Dosage FormPowder, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date1983-07-20
Marketing CategoryBLA / BLA
Application NumberBLA101246
Labeler NameRECORDATI RARE DISEASES, INC.
Substance NameHEMIN
Active Ingredient Strength7 mg/mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 55292-702-55

1 VIAL in 1 CARTON (55292-702-55) > 48 mL in 1 VIAL (55292-702-54)
Marketing Start Date1983-07-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55292-702-55 [55292070255]

Panhematin POWDER, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA101246
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1983-07-20

NDC 55292-702-54 [55292070254]

Panhematin POWDER, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA101246
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1983-07-20

Drug Details

Active Ingredients

IngredientStrength
HEMIN7 mg/mL

OpenFDA Data

SPL SET ID:9984267a-4d57-4444-9bb5-16bca7dea691
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1926454
  • 1926452
  • NDC Crossover Matching brand name "Panhematin" or generic name "Hemin"

    NDCBrand NameGeneric Name
    55292-701Panhematinhemin
    55292-702Panhematinhemin

    Trademark Results [Panhematin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PANHEMATIN
    PANHEMATIN
    73451832 1317567 Live/Registered
    Abbott Laboratories
    1983-11-07

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.